Macquarie Group’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,770
| Closed | -$60K | – | 2566 |
|
|
2022
Q2 | $60K | Hold |
5,770
| – | – | ﹤0.01% | 2006 |
|
|
2022
Q1 | $51 | Hold |
5,770
| – | – | ﹤0.01% | 2136 |
|
|
2021
Q4 | $40K | Hold |
5,770
| – | – | ﹤0.01% | 2232 |
|
|
2021
Q3 | $72K | Buy |
5,770
+4,393
| +319% | +$63.3K | ﹤0.01% | 2094 |
|
|
2021
Q2 | $25K | Hold |
1,377
| – | – | ﹤0.01% | 2322 |
|
|
2021
Q1 | $29K | Sell |
1,377
-422
| -23% | -$8.89K | ﹤0.01% | 2199 |
|
|
2020
Q4 | $32K | Hold |
1,799
| – | – | ﹤0.01% | 2138 |
|
|
2020
Q3 | $20K | Hold |
1,799
| – | – | ﹤0.01% | 2169 |
|
|
2020
Q2 | $25K | Buy |
+1,799
| New | +$24.8K | ﹤0.01% | 2126 |
|
|
2017
Q2 | – | Sell |
-18,415
| Closed | -$712K | – | 1562 |
|
|
2017
Q1 | $712K | Sell |
18,415
-572
| -3% | -$24K | ﹤0.01% | 1255 |
|
|
2016
Q4 | $722K | Buy |
18,987
+3,263
| +21% | +$155K | ﹤0.01% | 1244 |
|
|
2016
Q3 | $851K | Sell |
15,724
-24,916
| -61% | -$1.27M | ﹤0.01% | 1192 |
|
|
2016
Q2 | $1.49M | Buy |
+40,640
| New | +$1.44M | ﹤0.01% | 1204 |
|
Other funds holding RDUS
Macquarie Group's RDUS Position: Q3 2022 in Review
Macquarie Group sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 5,770 shares — an estimated $60K sold.
Macquarie Group first reported a position in RDUS in Q2 2016 and held it in 13 quarters. The position peaked at $1.49M in Q2 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Macquarie Group reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Macquarie Group sold 5,770 Radius Health, Inc. shares in Q3 2022, an estimated $60K.
- Macquarie Group first reported a position in Radius Health, Inc. in Q2 2016 and held it in 13 quarters.
- Macquarie Group's Radius Health, Inc. position peaked at $1.49M in Q2 2016.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.